Literature DB >> 3380785

The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove.

J A Rice1, D M Crothers, A L Pinto, S J Lippard.   

Abstract

We used gel electrophoresis methods to show that reaction of DNA with cis-diamminedichloroplatinum(II) results in a substantial (approximately equal to 40 degrees) bend in the double helix at the intrastrand crosslink between the N7 atoms of adjacent guanosine nucleosides, which bond to the platinum(II) complex with loss of two chloride ions. Multimers of a 22-base-pair (bp) oligonucleotide platinated at a single site show strong anomalies in their electrophoretic mobilities as a consequence of coherent addition of in-phase platinum-induced bends. Increase of the sequence repeat of the platinated site to 27 bp yields multimers of nearly normal mobility because the bends are out of phase. The direction of Pt-induced bends relative to adenosine-tract bends was determined from the electrophoretic mobility of multimers in which repeated platination sites are interdigitated at various phasings relative to repeated adenosine tracts. Optimum bending occurs when 1.5 helical turns separate the cis-[Pt(NH3)2[d(pGpG)]](N7,N7) adducts from the center of the adenosine tracts. This phasing produces coherent addition of adenosine tract bends toward the minor groove at their centers and Pt-induced bends toward the major groove, where the platinum is located.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380785      PMCID: PMC280385          DOI: 10.1073/pnas.85.12.4158

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Bending and flexibility of kinetoplast DNA.

Authors:  S D Levene; H M Wu; D M Crothers
Journal:  Biochemistry       Date:  1986-07-15       Impact factor: 3.162

2.  Calibration of DNA curvature and a unified description of sequence-directed bending.

Authors:  H S Koo; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Curved DNA: design, synthesis, and circularization.

Authors:  L Ulanovsky; M Bodner; E N Trifonov; M Choder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  Molecular mechanics modeling of oligonucleotide adducts of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  J Kozelka; S Archer; G A Petsko; S J Lippard; G J Quigley
Journal:  Biopolymers       Date:  1987-08       Impact factor: 2.505

5.  DNA bend direction by phase sensitive detection.

Authors:  S S Zinkel; D M Crothers
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

6.  The mechanism of action of antitumor platinum compounds.

Authors:  J J Roberts; A J Thomson
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1979

7.  Cis- and trans-diamminedichloroplatinum(II) binding products different tertiary structural changes on SV40 DNA.

Authors:  W M Scovell; L R Kroos
Journal:  Biochem Biophys Res Commun       Date:  1982-02-26       Impact factor: 3.575

8.  X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))].

Authors:  S E Sherman; D Gibson; A H Wang; S J Lippard
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

9.  Binding of cis- and trans-dichlorodiammineplatinum(II) to DNA: evidence for unwinding and shortening of the double helix.

Authors:  G L Cohen; W R Bauer; J K Barton; S J Lippard
Journal:  Science       Date:  1979-03-09       Impact factor: 47.728

10.  cis-diamminedichloroplatinum(II) induced distortion of a single and double stranded deoxydecanucleosidenonaphosphate studied by nuclear magnetic resonance.

Authors:  J H den Hartog; C Altona; J H van Boom; G A van der Marel; C A Haasnoot; J Reedijk
Journal:  J Biomol Struct Dyn       Date:  1985-06
View more
  34 in total

1.  Curved DNA without A-A: experimental estimation of all 16 DNA wedge angles.

Authors:  A Bolshoy; P McNamara; R E Harrington; E N Trifonov
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Diepoxybutane interstrand cross-links induce DNA bending.

Authors:  Julie T Millard; Erin E McGowan; Sharonda Q Bradley
Journal:  Biochimie       Date:  2011-08-04       Impact factor: 4.079

Review 3.  Biological properties of single chemical-DNA adducts: a twenty year perspective.

Authors:  James C Delaney; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2007-12-12       Impact factor: 3.739

4.  Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.

Authors:  Evan R Guggenheim; Dong Xu; Christiana X Zhang; Pamela V Chang; Stephen J Lippard
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

5.  B----Z DNA conformational changes induced by a family of dinuclear bis(platinum) complexes.

Authors:  A Johnson; Y Qu; B Van Houten; N Farrell
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

6.  Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides.

Authors:  K J Mellish; Y Qu; N Scarsdale; N Farrell
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

7.  DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

Authors:  J Malina; C Hofr; L Maresca; G Natile; V Brabec
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

8.  Crystal lattice packing is important in determining the bend of a DNA dodecamer containing an adenine tract.

Authors:  A D DiGabriele; M R Sanderson; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  Identification of DNA--cisplatin adducts in a blind trial of in situ scanning tunneling microscopy.

Authors:  A M Jeffrey; T W Jing; J A DeRose; A Vaught; D Rekesh; F X Lu; S M Lindsay
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

10.  A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors.

Authors:  Bastiaan Evers; Eva Schut; Eline van der Burg; Tanya M Braumuller; David A Egan; Henne Holstege; Pauline Edser; David J Adams; Richard Wade-Martins; Peter Bouwman; Jos Jonkers
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.